US Broker Ratings

Corcept Therapeutics (CORT) Stock Analysis: Uncovering a 25% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology industry, is garnering attention for its innovative approach to treating severe endocrinologic, oncologic, metabolic, and neurologic..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: An 18% Upside Potential Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotech industry, is capturing investor attention with a compelling growth trajectory and a robust portfolio of..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 38% Potential Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is making waves in the healthcare sector, particularly within the Diagnostics & Research industry. With a formidable market cap of $39.76..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 39% Potential Upside in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, particularly within the burgeoning field of medical devices, Globus Medical, Inc. (NYSE: GMED) presents a compelling case. With..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 45% Upside Potential

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $62.29..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Competitive Healthcare Landscape with Cautious Optimism

Avantor, Inc. (NYSE: AVTR) stands as a key player in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in Radnor, Pennsylvania, and..

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 17.48% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands as a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in South..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 23.28% Upside in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD) has recently captured the attention of investors with its innovative approach in the healthcare sector, specifically within the biotechnology industry. Boasting..

ICON plc (ICLR) Stock Analysis: Unpacking a 9.6% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading clinical research organization, stands at an intriguing juncture for investors seeking exposure in the healthcare sector. With a market capitalization..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 31% Upside Potential Amid Healthcare Innovation

Koninklijke Philips N.V. (NYSE: PHG), a Dutch healthcare technology leader, presents a compelling opportunity for investors with a potential upside of nearly 31% based on current..

Teleflex Incorporated (TFX) Stock Analysis: A 17.22% Potential Upside Amidst Strong Revenue Growth

Investors eyeing opportunities in the healthcare sector may find Teleflex Incorporated (NYSE: TFX) an intriguing option, especially with an enticing potential upside of 17.22% based on..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 10.20% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates within the Diagnostics & Research industry and boasts a market capitalization of $25.27..

Quest Diagnostics (DGX): Investor Outlook Highlights 4.98% Potential Upside

As investors navigate the intricate landscape of healthcare equities, Quest Diagnostics Incorporated (NYSE: DGX) emerges as a noteworthy consideration. With its roots entrenched in the diagnostics..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Promising 89% Upside Potential in the Biotech Sector

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology industry, is capturing investor attention with its compelling growth story and substantial upside potential. Based..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 9.23% Potential Upside with Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB) remains a captivating prospect for investors seeking exposure in the healthcare sector, particularly within the pharmaceutical landscape. With its strategic focus on..

Danaher Corporation (DHR) Stock Analysis: Strong Buy Ratings and 14% Upside Potential

For investors eyeing opportunities in the healthcare sector, Danaher Corporation (NYSE: DHR) presents a compelling proposition. With its robust $140.7 billion market cap, Danaher stands as..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating a 33.64% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Silver..

Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings and a 14.85% Upside Potential

Cencora, Inc. (COR), a healthcare titan in the medical distribution industry, continues to capture investor attention with its robust market presence and promising growth prospects. With..

Insulet Corporation (PODD) Stock Analysis: Eyeing a 30% Upside Amid Strong Revenue Growth

Investors with a keen eye on the healthcare sector may find Insulet Corporation (NASDAQ: PODD) an intriguing prospect, especially given its current market position and potential..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Robust Growth in Healthcare Diagnostics with a 5.54% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV) continues to make compelling strides in the healthcare sector, showcasing a promising trajectory for investors seeking exposure to the diagnostics and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds